OncoLens
5 known investors
OncoLens is an AI-enabled digital health platform that extracts and analyzes structured and unstructured clinical, pathology, and lab data from EMRs to support oncology workflows such as tumor board operations, clinical trial matching, registry reporting, and real-world evidence generation. It serves cancer centers, oncology providers, and life science/pharma partners through its research network connecting them for trials and data projects.
Investors · 5
Frequently asked questions
- What does OncoLens do?
- OncoLens is an AI-enabled digital health platform that extracts and analyzes structured and unstructured clinical, pathology, and lab data from EMRs to support oncology workflows such as tumor board operations, clinical trial matching, registry reporting, and real-world evidence generation. It serves cancer centers, oncology providers, and life science/pharma partners through its research network connecting them for trials and data projects.
- Who are OncoLens's investors?
- OncoLens's investors include Atlanta Technology Angels, BIP Ventures, Cross-Border Impact Ventures, Martin Ventures, SeedToB.